IL6 and Parkinson disease: Finally, histologic data showed increases in the immunoreactivity of the astrocytic marker GFAP in the colon of PD patients as well as increases in TNF-α, IFN-γ, IL-6, and IL-1β levels (142) (Figure 3A).